GLB Stock Overview
Operates as a nutrition company worldwide. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
Glanbia plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €14.52 |
52 Week High | €19.62 |
52 Week Low | €14.00 |
Beta | 0.51 |
11 Month Change | -10.26% |
3 Month Change | -9.19% |
1 Year Change | -3.84% |
33 Year Change | 16.21% |
5 Year Change | 36.08% |
Change since IPO | 1,608.24% |
Recent News & Updates
Recent updates
Shareholder Returns
GLB | GB Food | GB Market | |
---|---|---|---|
7D | -3.2% | -2.6% | 0.7% |
1Y | -3.8% | 3.7% | 6.1% |
Return vs Industry: GLB underperformed the UK Food industry which returned 3.7% over the past year.
Return vs Market: GLB underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
GLB volatility | |
---|---|
GLB Average Weekly Movement | 9.0% |
Food Industry Average Movement | 3.8% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GLB's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: GLB's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1964 | 5,534 | Hugh McGuire | www.glanbia.com |
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Glanbia plc Fundamentals Summary
GLB fundamental statistics | |
---|---|
Market cap | €3.74b |
Earnings (TTM) | €282.67m |
Revenue (TTM) | €4.25b |
13.2x
P/E Ratio0.9x
P/S RatioIs GLB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GLB income statement (TTM) | |
---|---|
Revenue | US$4.47b |
Cost of Revenue | US$3.27b |
Gross Profit | US$1.20b |
Other Expenses | US$906.60m |
Earnings | US$297.30m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.16 |
Gross Margin | 26.94% |
Net Profit Margin | 6.65% |
Debt/Equity Ratio | 44.0% |
How did GLB perform over the long term?
See historical performance and comparison